Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 14Lung Neoplasms 11Colonic Neoplasms 9Breast Neoplasms 9Brain Neoplasms 7Prostatic Neoplasms 4Emergence Delirium 4Urinary Bladder Neoplasms 3Stomach Neoplasms 3Rectal Neoplasms 3Pituitary Neoplasms 3Neoplastic Cells, Circulating 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Agnosia 3Supratentorial Neoplasms 2Respiratory Aspiration 2Postoperative Complications 2Pain, Postoperative 2Ovarian Neoplasms 2Neoplasm Metastasis 2Melanoma 2Liver Neoplasms 2Hypoxia 2Delirium 2Colorectal Neoplasms 2Abdominal Neoplasms 2Uterine Neoplasms 1Tuberculosis, Pulmonary 1Thyroid Nodule 1

Interventions

Sevoflurane 1Propofol 1Patient Discharge 1Nitrous Oxide 1Lidocaine 1Glycopyrrolate 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hydrocephalus × Propofol × Clear all
NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡